Boston Scientific Takes Conor to Court over DES

Boston Scientific has filed suite in the Netherlands to keep Conor Medsystems from selling its paclitaxel-coated stent in Europe. This is the latest effort by interventional cardiology companies to use litigation to protect market share.

All market share wars are, to one degree or another, fought on multiple fronts. While companies pursue aggressively a forward strike to convince customers to buy more products, they also, when appropriate, engage in a rear-guard action to keep other competitors from entering the market. Nowhere is this truer than in markets like interventional cardiology, where even small differences in design features can have a huge impact on product performance and thus are often crucial to customer adoption. The latest such rear-guard action: the lawsuit filed this past February in The Netherlands by Boston Scientific Corp. to keep Conor Medsystems Inc. from selling its paclitaxel-coated stent in Europe.

The suit itself was hardly a surprise. Boston Scientific officials had been saying publicly for several months that they felt...

More from Archive

More from In Vivo

Podcast: ADDF’s Karen Harris On Investing In Alzheimer’s Like A VC

 
• By 

A discussion with Karen Harris, CFO of the Alzheimer's Drug Discovery Foundation, about the foundation's investment strategy, biotech and investor sentiment at the recent BIO conference and what innovations give her hope for Alzheimer's patients.

Turning Defense Into Attack: Snapshots Of A Changing Medtech Market And How To Respond

 
• By 

Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

 
• By 

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.